Free Newsletter
Trials test ultrasound as cancer weapon
Scientists at the University of Oxford are preparing clinical trials to test a new way to treat kidney and liver tumors. Ultrasound waves will be directed to tumors, where bubbles will develop and pop, releasing heat and killing cancer cells. High Intensity Focused Ultrasound, or Hifu, has several advantages over surgery. Patients will not need to be opened up and healthy tissue will be left relatively untouched. The researchers are working with the same kind of technology employed by a microwave, where waves are used to heat material. So far, they have developed a very slow procedure that works on tumors that are difficult to reach. Hifu promises to increase the heat level as bubbles are created and then explode, causing the therapeutic effect.
- read the report from the BBC
Related Articles:
FDA to slap black box on ultrasound drugs. Report
Nanoparticles used to destroy tumors. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: